Autor: "Mechtler, L." - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Patient-reported migraine-specific quality of life, activity impairment and headache impact with once-daily atogepant for preventive treatment of migraine in a randomized, 52-week trial.
Autorzy:: Lipton RB; Albert Einstein College of Medicine, Bronx, NY, USA.
Halker Singh RB; Mayo Clinic, Scottsdale, AZ, USA.
Mechtler L; Dent Neurologic Institute, Buffalo, NY, USA.
McVige J; Dent Neurologic Institute, Buffalo, NY, USA.
Ma J; AbbVie, Madison, NJ, USA.
Yu SY; AbbVie, Irvine, CA, USA.
Stokes J; AbbVie, Madison, NJ, USA.
Dabruzzo B; AbbVie, Madison, NJ, USA.
Gandhi P; AbbVie, Madison, NJ, USA.
Ashina M; Danish Headache Center, Rigshospitalet Glostrup, University of Copenhagen, Denmark.; Pokaż więcej
Źródło:: Cephalalgia : an international journal of headache [Cephalalgia] 2023 Aug; Vol. 51 (8), pp. 3331024231190296.
Typ publikacji:: Randomized Controlled Trial; Multicenter Study; Journal Article
MeSH Terms:: Quality of Life*
Piperidines*/administration & dosage
Piperidines*/therapeutic use
Pyridines*/administration & dosage
Pyridines*/therapeutic use
Pyrroles*/administration & dosage
Pyrroles*/therapeutic use
Spiro Compounds*/administration & dosage
Spiro Compounds*/therapeutic use
Calcitonin Gene-Related Peptide Receptor Antagonists*/administration & dosage
Calcitonin Gene-Related Peptide Receptor Antagonists*/therapeutic use
Migraine Disorders*/prevention & control
Humans ; Patient Reported Outcome Measures ; Drug Administration Schedule

Czasopismo naukowe

Skocz do pozycji: 2.

Tytuł:: Safety and tolerability results of atogepant for the preventive treatment of episodic migraine from a 40-week, open-label multicenter extension of the phase 3 ADVANCE trial.
Autorzy:: Klein BC; Abington Neurological Associates, Ltd., Abington, PA, USA.
Miceli R; AbbVie Inc., Madison, NJ, USA.
Severt L; AbbVie Inc., Madison, NJ, USA.
McAllister P; New England Institute for Neurology & Headache, Stamford, CT, USA.
Mechtler L; DENT Neurologic Institute, Amherst, NY, USA.
McVige J; DENT Neurologic Institute, Amherst, NY, USA.
Diamond M; Diamond Headache Clinic, Chicago, IL, USA.
Marmura MJ; Jefferson Headache Center, Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.
Guo H; AbbVie Inc., Madison, NJ, USA.
Finnegan M; AbbVie Inc., Madison, NJ, USA.
Trugman JM; AbbVie Inc., Madison, NJ, USA.; Pokaż więcej
Źródło:: Cephalalgia : an international journal of headache [Cephalalgia] 2023 Jan; Vol. 43 (1), pp. 3331024221128250.
Typ publikacji:: Multicenter Study; Journal Article
MeSH Terms:: Migraine Disorders*/drug therapy
Migraine Disorders*/prevention & control
Humans ; Treatment Outcome ; Double-Blind Method ; Nausea

Czasopismo naukowe

Skocz do pozycji: 3.

Tytuł:: Type 1 Primary Cutaneous Meningioma with Atretic Meningocele.
Autorzy:: Pillai B; Department of Neurology, Amrita Institute of Medical Sciences, Kochi, Kerala, India.
Sapkota M; Department of Neurology, Geisinger Medical Center, Philadelphia, USA.
Farooque U; Department of Internal Medicine, Dow Medical College, Karachi, Pakistan.
Asghar F; Department of Neurology, Dow Medical College, Karachi, Pakistan.
Perez A; Department of Neurology, University of Buffalo, Buffalo, New York, USA.
Mechtler L; Dent Neurological Institute, Buffalo, New York, USA.; Pokaż więcej
Źródło:: Annals of Indian Academy of Neurology [Ann Indian Acad Neurol] 2021 Mar-Apr; Vol. 24 (2), pp. 278-280. Date of Electronic Publication: 2020 Sep 02.
Typ publikacji:: Journal Article

Czasopismo naukowe

Informacja